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ABSTRACT 
 
Infections caused by multidrug-resistant (MDR) bacteria, including Vancomycin-Resistant 
Enterococcus (VRE), have become one of the greatest clinical challenges of the 21
st
 century. Particularly, 
VRE strains of E. faecium, a natural member of the gastrointestinal consortia, have recently emerged as 
one of the most problematic cases of MDR nosocomial pathogens. It is widely known that the 
establishment of high-level intestinal colonization of this bacterium, triggered by antibiotic treatment of 
the host, potentially leads to bacteremia, endocarditis and surgical wound, urinary tract, and device-
related infections in hospitalized patients. However, the unique determinants possessed by these 
strains, which enable them to benefit from the antibiotic-induced perturbations of the gut microbiota 
and host intestinal immune defenses, remain to be identified.  
 
Essentially, what needs to be revealed is the differential gene expression of E. faecium in its 
niche at different time points; before and during antibiotic treatment of the host, and very interestingly, 
in the presence of probiotic bacteria. Differentially expressed genes will highlight how and why E. 
faecium is able to dominate the gut, as well as how it interacts with its surroundings, possibly 
pinpointing its potential weaknesses, as well as provide hints on what specific properties should be 
prerequisites for bacteria to be used as probiotics.    
 
Since the global expression intended to be analyzed is that of E. faecium alone, a method to 
separate this bacteria from the rest of the gut microbiota is required. Failure to do so would result in the 
study of the gut microbiota’s transcriptome as a whole: metatranscriptomics. In practice, the separation 
VRE. faecium from the rest of the commensal microbiota could be carried out by means of flow 
cytometry if the generation of a fluorescent E. faecium was achieved. Additionally, it would serve as a 
great tool to study a series of facets of VRE faecium colonization which remain virtually unknown. It 
would enable the monitorization of VRE infection through whole-body imaging of infected mice, 
fluorescence microscopy analysis of histological cuts to determine its most predominant locations, the 
use of FbFP as a translational or transcriptional reporter, etc. 
 
    Consequently, the main objective of this Final Degree Project has been to attempt the 
generation of a Vancomycin-Resistant Enterococcus faecium clinical isolate (C68) expressing a 
fluorescent protein whose chromophore can form under the anaerobic conditions found in the guts of 
animals: (FMN)-based fluorescent protein (FbFP).  
 
In order to fulfill the main objective of this work, first, the FbFP gene was synthesized with the 
appropriate features for its expression in E. faecium and for its cloning. Next, the plasmid construction 
aimed to confer E. faecium fluorescent properties (pBT2-FbFP), was generated. This was done by 
inserting the FbFP gene into the pBT2 plasmid. As a previous step to the transformation of E. faecium, 
pBT2-FbFP was transformed into E.coli DH5a in order more efficiently validate the integrity of the 
plasmid construction. After validation, E faecium was finally transformed and the corresponding 
fluorescence analyses were performed.  
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RESUMEN: 
 
Las infecciones causadas por bacterias resistentes a múltiples fármacos (MDR), incluyendo el 
Enterococo resistente a la vancomicina (VRE), se han convertido en uno de los mayores retos clínicos del 
siglo 21. En particular, las cepas de E. faecium, miembro natural de la microbiota gastrointestinal, 
suponen actualmente uno de los casos más problemáticos de MDR patógenos nosocomiales. La 
colonización intestinal con altos niveles de esta bacteria es provocada por el tratamiento con 
antibióticos y puede producir bacteriemia, endocarditis, infecciones del tracto urinario y de heridas 
quirúrgicas o relacionadas con dispositivos médicos, en pacientes hospitalizados. Sin embargo, aún no se 
han identificado los determinantes específicos que les permiten a estas cepas beneficiarse de las 
alteraciones inducidas por los antibióticos sobre la microbiota y las defensas del sistema inmune 
intestinal.  
 
En esencia, se necesita conocer la expresión diferencial de los genes de E. faecium en su nicho y 
en diferentes momentos: antes y durante el tratamiento con antibióticos, así como en presencia de 
bacterias probióticas. Los genes expresados diferencialmente pondrían de relieve cómo y por qué E. 
faecium es capaz de dominar el intestino o la forma en que interactúa con su entorno, posibilitando la 
localización de sus debilidades potenciales y mostrando qué propiedades específicas deberían ser 
requisitos previos de una bacteria para ser utilizada como probiótico.  
 
Dado que la expresión global a analizar es la de E. faecium solo, se necesita un método para 
separar esta bacteria del resto de la microbiota intestinal. No hacerlo, daría lugar al estudio del 
transcriptoma de la microbiota intestinal en su conjunto: metatranscriptómica. En la práctica, la 
separación de VRE faecium del resto de la microbiota comensal podría llevarse a cabo por medio de 
citometría de flujo una vez lograda la generación de un E. faecium fluorescente. Además, constituiría 
una gran herramienta para el estudio de una serie de facetas de la colonización de VRE faecium que 
siguen siendo prácticamente desconocidas. Por ejemplo, permitiría la monitorización de la infección por 
VRE a través de imágenes del cuerpo de ratones infectados, el análisis de microscopía de fluorescencia 
de cortes histológicos para determinar sus principales localizaciones, el uso de FbFP tanto como 
reportero transcripcional como de traducción, etc.  
 
Por ello, el objetivo principal de este Trabajo de Fin de Grado la generación de un aislado clínico 
(C68) vancomicina resistente de Enterococcus faecium a través de la expresión de una proteína 
fluorescente cuyo cromóforo pueda formarse en las condiciones anaerobias de los intestinos de los 
animales: proteína fluorescente basada en FMN (FbFP).  
 
Con el fin de cumplir con el objetivo principal de este trabajo, el gen FbFP fue sintetizado con 
las características apropiadas para su expresión en E. faecium así como para su clonación. A 
continuación, se generó la construcción del plásmido destinado a conferir propiedades fluorescentes a 
E. faecium (pBT2-FbFP). Esto se hizo mediante la inserción del gen FbFP en el plásmido pBT2. Como paso 
previo a la transformación de E. faecium, pBT2-FbFP se transformó en E. coli DH5a con el fin de validar 
de manera más eficiente la integridad de la construcción del plásmido. Después de su validación, E. 
faecium fue transformado y se realizaron los correspondientes análisis de fluorescencia. 
 
Palabras clave: 
Enterococo vancomicína resistente (VRE), proteína fluorescente basada en FMN, Enterococcus faecium, 
resistencia a antibióticos 
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1. INTRODUCTION 
 
1.1 Emergence of Enterococci as a challenging nosocomial problem 
 
1.1.1 Enterococci  
 
The Enterococcus genus forms part of the Enterococcaceae family, along with other 
bacterial genera (Bavariicoccus, Catellicoccus, Melissococcus, Pilibacter, Tetragenococcus and 
Vagococcus) (Lebreton et al., 2014). It consists of species that are normally commensal 
bacteria of human and animal gastro-intestinal (GI) tracts, as well as of the guts of insects. 
However, some are also adapted to survive and persist in fermented foods, dairy products, and 
different environments such as plants, soil and water. 
 
These Gram-positive bacteria are characterized for being facultative anaerobic oval-
shaped cocci, which are often arranged in pairs or small chains. Although unable to form 
spores, these organisms have been capable of surviving in such a broad spectrum of niches as 
a result of their ability to survive harsh conditions: high salt concentrations, and broad ranges 
of pH (4.5-10.0) and temperature (10 ºC to >45 ºC).  
 
The taxonomy of enterococci has changed substantially over the past decade. At 
present, the genus includes more than forty distinct species adapted to various environments, 
with specific metabolic and phenotypic characteristics (Lebreton et al., 2014). It is of great 
importance to mention that E. faecalis and E. faecium are considered to be the most abundant 
enterococci species found in human fecal matter (Devriese et al., 1994), and evidence reflects 
that they also account for the majority of enterococci-related diseases currently reported 
(Malani et al., 2002) 
 
1.1.2 The human gut microbiome 
 
The human digestive system is home to trillions of microorganisms which play a key 
role in many different host-related processes and have a profound effect on human health and 
disease. This complex community of microorganisms is known as the gut microbiome and is 
often defined as “the vast collection of symbiotic microorganisms in the human 
gastrointestinal system and their collective interacting genomes” (Kimross et al., 2011). 
 
The gut flora comprises a highly organized ambiance, in which each species has a 
specific role, and where certain species balance other out, giving rise to a fluctuating, though 
relatively stable equilibrium. It has been described as an “extended genome” of the host, 
where millions of microbial genes are located in the GI tract (Lederberg, 2000). Therefore, it is 
not surprising that the human microbiome is bound to perform essential biochemical functions 
for the host, and that it plays an important role in our development, immunity, and nutrition 
(Kau et al., 2012).  
 
Alternatively, disorders of the microbiome are associated with various human disease 
processes (Kimross et al., 2011), and consequently, in recent years, a great amount of effort 
has been made by scientists all around the world to study the microbiome and its activity. It is 
clear that a further understanding of the human gut microbiome is crucial for the development 
of future personalized medicine strategies, along with the potential identification of new 
therapy targets for drug development. 
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1.1.3 Antibiotic resistance: Rise of antibiotic resistant Enterococci  
 
Antibiotic resistance is the ability of a microorganism to resist or evade the effects of a 
given antibiotic, and it occurs when the microorganism changes in some way which hampers 
the effectiveness of the drugs designed to cure or prevent its infections. As a result, these 
bacteria are capable of surviving and continue multiplying even under exposure to antibiotics. 
Multidrug resistant (MDR) bacteria or, more colloquially known as “superbugs”, are terms 
which refer to bacteria that are resistant to multiple antibiotics. This phenomenon is currently 
a major threat to public health, and it represents one of the major clinical challenges and 
health concerns of the 21st century.  
 
Resistance to antibiotics can be the result of spontaneous genetic mutations in genes 
involved in normal physiological processes and cell structures, and very importantly, 
additionally, through the acquisition of resistance genes from other bacteria by horizontal 
gene transfer, via conjugation, transduction or transformation (MICHIGAN STATE UNIVERSITY, 
2011). Resistance genes are frequently carried by vectors (plasmids, transposons or integrons) 
that transfer these genes to other bacteria, though not necessarily pertaining to the same 
genus or specie. 
 
Historically, Enterococci have been contemplated as second-rate pathogens due to the 
generally low virulence levels they display, evidenced by their ubiquitous presence in the 
human GI tract (Lebreton et al., 2014). However, factors such as the enormous plasticity of 
their genomes (acquired elements can comprise up to 25% of the genome), innate resistance 
to some antimicrobial agents (clindamycin, cephalosporins, aminoglycosides), ability to gain 
and spread antibiotic resistance genes, and their ability to survive long periods of time on 
environmental surfaces, contribute to the transformation of this second-rate pathogen into a 
first-class clinical challenge. 
 
Although E. faecalis and E. faecium are currently the most frequent Enterococci fecal 
isolates and account for the majority of infections today, before mid-1990s E. faecium 
infections were rare, and E. faecalis accounted for 90–95% of clinical isolates (Lebreton et al., 
2014; Lebreton et al., 2014). Nonetheless, ever since, E. faecium isolates have increased in 
proportion, a fact that hasn't passed unnoticed to many researchers in the field, and which 
most attribute to the dispersion of antibiotic resistance (vancomycin and ampicillin resistance 
in particular), a phenomenon highly associated with the increased use of vancomycin and 
other broad-spectrum antibiotics (Arias and Murray, 2012; Gilmoreet al., 2013; Lebreton et al., 
2014). It can be said that within the Enterococcus genus, E. faecium has emerged as the most 
therapeutically challenging organism (Arias and Murray, 2012). 
 
Repercussions of this emerging problem are clinically dramatic. As mentioned earlier, 
some E. faecium strains possess unique traits which enable them to exploit their selective 
advantage over the rest of the gut microbiota under antibiotic exposure. The opportunistic 
facet of E. faecium is especially enhanced in the hospital setting, where antibiotic treatment is 
widespread. This environment, as described in detail in the next section, enables it to rise as a 
multidrug-resistant nosocomial pathogen, becoming a major clinical challenge in hospitals, and 
which potentially causes bacteremia and endocarditis, in addition to surgical wound, urinary 
tract and device-related infections in debilitated patients (Zang et al., 2013). 
 
1.1.4 Gastro-intestinal tract colonization and the effect of antibiotic treatment 
 
Despite the universal presence of Enterococci in the GI tracts of humans and animals, 
they habitually constitute a small percentage of the gut consortium, naturally comprising only 
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less than 1% of the adult microflora (Finegold et al, 1983; Sghir et al, 2000; Lebreton et al 
2014). However, the use of antibiotics in hospitalized patients results in a substantial alteration 
of the gut microbiota, which in turn promotes the colonization by drug-resistant enterococci 
(Donskey et al., 2000). 
 
There is insufficient understanding of the mechanisms by which enterococci are able 
to conquer the GI tracts of either healthy individuals or hospitalized patients. Nonetheless, it is 
widely known that the settlement of a prominent intestinal colonization by drug-resistant 
Enterococci is a decisive step in a process that can culminate in serious nosocomial infections 
(Arias and Murray, 2012). Once E. faecium has become the predominant species in the GI tract, 
it may access the bloodstream by crossing the intestinal lining, causing bacteremia and 
infective endocarditis (Ubeda et al., 2010). Additionally, and taking into account the long 
survival period of Enterococci on environmental surfaces, this stage can also serve as a 
reservoir for fecal contamination of the skin and urinary tract, as well as for its dissemination 
in the hospital setting, altogether leading to catheter-related infections (Arias and Murray, 
2012). 
 
It is widely known that commensal microbiota normally aids in the protection against 
Gram-positive pathogens. Alterations in the susceptible microbiota triggered by antibiotics 
enhance the rise of drug-resistant enterococci as the dominant members of the GI tract, 
potentially leading to a severe clinical impact. The main reason for this phenomenon is the fact 
that commensal bacteria compete with Enterococci for the resources in the niche and produce 
substances which inhibit their growth and spread.  Moreover, recent studies (Ubeda et al., 
2010; Arias and Murray, 2012) have also shed light on the fact that antibiotic-depletion of the 
microbiota alters the immune defenses of the host (reduction of REGIII secretion), thereby 
indirectly facilitating colonization of the intestines by MDR Enterococci. 
 
     1.1.5 Commensal bacteria can prevent/combat Vancomycin-Resistant Enterococcus 
(VRE) infections (probiotics) 
 
As explained in the previous section, the presence of a healthy gut microbiota is 
beneficial for the host, not only because it performs essential biochemical functions for the 
host, but also because it is key for keeping opportunistic bacteria (ei. E. faecium) in place. 
Notably, the beneficial effects of commensal bacteria have raised awareness on its potential 
use as probiotics. Basically, the idea behind the use of probiotics is the restoration of beneficial 
bacteria which can help the host fight infection by killing harmful bacteria, either directly 
(actively attacking other bacteria with bacteriocins and competing for the same resources in 
the niche), or indirectly (through the activation of the immune response). With the number of 
drug-resistant bacteria on the rise, and taking into account the time-consuming and tedious 
process antibiotic development entails, this alternative presents itself as ever more appealing. 
 
Recent studies demonstrate that the transference of a healthy donor’s microbiota into 
a sick recipient by means of bacteriotherapy (fecal transplantation), can prompt its recovery 
through the reestablishment of its normal microflora (Khoruts et al., 2010). Therefore, directed 
manipulation of the gut microbiome presents itself as clinically promising. In relation to VRE, E. 
faecium in particular, studies carried out by the co-supervisor of this Final Degree Project were 
able to identify bacterial populations which correlate with the elimination of this pathogen in 
the GI tracts of mice (Ubeda et al., 2013). So far, it appears that bacteria pertaining to 
Barnesiella genus protect the GI tract of its host from VRE domination. Withal, it is very likely 
that other bacterial genera may also contribute to VRE elimination, and that, rather than a 
complete recovery of the microbiota, the recovery of just a few key members could be 
sufficient for VRE clearance.  
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In the foreseeable future, MDR enterococci are expected to continue posing a huge 
public health challenge. The trends in the epidemiology of enterococcal infections suggest that 
VRE faecium may become the most common species isolated from hospitalized patients soon 
(Kristich et al., 2014). As a result, novel therapeutic strategies focused on treating the 
infections provoked by these organisms are urgently needed. The probiotic approach is the 
one being taken by the lab department in which this “Final Degree Project” was carried out.  
 
1.2 Importance of a complete Transcriptome study 
 
The specific genetic determinants which promote the GI tract colonization of 
nosocomial E. faecium strains during antibiotic treatment remain to be identified (Zang et al., 
2013). Until light is shed on the unique traits that enable this pathogen to benefit from the 
antibiotic-induced perturbations of the gut, it will continue to deceive our clinical barriers, 
hence threatening the lives of countless hospitalized patients. Studies focusing on revealing 
the key differences between the community-associated (commensal) and the nosocomial E. 
faecium are those of most urgent need. Essentially, what needs to be revealed is the 
differential gene expression of E. faecium in its niche at different time points; before and 
during antibiotic treatment of the host, and very interestingly, in the presence of probiotic 
bacteria. Differentially expressed genes will highlight how and why E. faecium is able to 
dominate the gut, as well as how it interacts with its surroundings, possibly pinpointing its 
potential weaknesses. This will provide hints on what specific properties should be 
prerequisites for bacteria to be used as probiotics.    
 
To study this, transcriptomic tools are required. Transcriptomics is defined as “the 
study of the complete set of RNAs (transcriptome) encoded by the genome of a specific cell or 
organism at a specific time or under a specific set of conditions”.  Fundamentally, there are 
three techniques for tackling the transcriptome: Real-time quantitative PCR (qPCR), 
microarray-based expression profiling and Next-Generation sequencing technologies 
(specifically a technology known as “RNA-Seq”).   
 
Although the qPCR technique is remarkably quantitative and sensitive, it would not be 
suitable for analyzing the differential expression of E. faecium, for it is designed to interrogate 
a relatively small number of transcripts, hence defeating the purpose of a global expression 
analysis. However, both microarrays and RNA-Seq could offer global surveys of the 
transcriptome, and could thereupon be used for this purpose (Perkel, 2013). On one hand, 
microarrays are biased, only capable of detecting homologous sequences to those on the 
array, but, the technology is widely available, simple and economical. On the other hand, RNA-
Seq is unbiased, though it remains expensive and computationally challenging. 
 
Since a global expression analysis is required, both the microarray and RNA-Seq 
technologies could be used, though RNA-Seq seems more suitable as a result of its unbiased 
output. However, certain aspects must be taken into account. Since the global expression 
analysis intended to be analyzed is that of E. faecium alone, a method to separate this bacteria 
from the rest of the gut microbiota is required. Failure to do so would result in the study of the 
gut microbiota’s transcriptome as a whole: metatranscriptomics. Furthermore, taking into 
account that under certain conditions VRE only represents a minor population of the 
microbiota, conducting RNA-Seq without previous separation of this bacterium would 
ultimately result in an output highly enriched with non-VRE sequences. Likewise, Microarray 
analysis of gene expression without taking the effort to separate the bacteria of interest would 
result in an outcome enriched with false positives, since homologous sequences from other 
commensal bacteria would bind to the probes on the chip. 
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1.3 (FMN)-based fluorescent proteins (FBFP’s)  
 
In practice, E. faecium could be separated from the rest of the commensal microbiota 
using flow cytometry, a technique that is widely used for counting and sorting microscopic 
particles, by suspending them in a stream of fluid and passing them through an electronic 
detection apparatus (UNIVERSITÉ DE PICARDIE JULES VERNE, 2014). This technique can be 
coupled to automated cell sorting devices which can sort successive droplets of the stream 
into different fractions by reason of the fluorescence emitted by each droplet (FACS: 
Fluorescence-activated cell sorting). Therefore, construction of a fluorescent VRE faecium 
clone would be of great interest for its in vivo separation from the rest of the microbiota, my 
means of FACS. 
 
It is important to highlight that there are a series of fluorescent reporter proteins 
which are currently used as noninvasive molecular tools for in vivo real-time imaging, like for 
example, GFP-like proteins (green fluorescent protein) (Drepper et al., 2007). However, a 
considerable drawback of the members of the GFP family is that their utility is restricted to 
aerobic systems, since molecular oxygen is strictly required for the correct formation of their 
chromophores.  This handicap motivated some researchers to generate Flavin mononucleotide 
(FMN)-based fluorescent proteins (FbFPs), which can be used as fluorescent reporters under 
both aerobic and anaerobic conditions. It is important to highlight the importance of the 
development of these proteins for studies involving fluorescence in the guts of animals, since 
these are anaerobic environments. These proteins were derived from the bacterial blue-light 
photoreceptors YtvA (from Bacillus subtilis), and SB2 (from Pseudomonas putida) that contain 
the light oxygen voltage (LOV) domains. In the engineered protein, the absorption peak is 
found at 449 nm, and its emission apex is 495 nm upon excitation with blue light (450 nm).  
 
    In this way, the generation of a VRE faecium clone expressing FbFP could be used to infect 
mice and subsequently recover it from feces at different time points and under different 
conditions (antibiotic treatment, presence of other bacteria, etc.), in order to separate it by 
means of FACS and study its transcriptome. This is one of the main objectives of the 
department in which this project was carried out. 
 
1.4 Further applications of a fluorescent VRE faecium clone 
     
In addition to its usefulness for global expression analyses, a fluorescent VRE faecium 
clone could be a great tool to study a series of facets of VRE faecium colonization which remain 
virtually unknown. For instance, whole-body imaging of VRE infected mice could be used for 
imaging the course of infection and its response to antibiotics or probiotics. Similar approaches 
have only been attempted through high expression levels of GFP-like proteins (Hoffman and 
Zhao, 2007), though FbFP appears more promising due to its fluorescent properties under 
anaerobic condition. This technique presents itself as non-invasive, for it enables imaging of 
FbFP-expressing bacteria from outside intact infected mice. Consequently, the temporal and 
spatial behavior of the infectious process could be monitored in great detail, making possible 
the determination of the spatial migration, tissue-specificity and response of VRE to chemical 
or biological agents.  
 
Furthermore, little is known about the in vivo interaction of these microorganisms 
with the GI epithelium of colonized mice. Fluorescence microscopy could be used to study 
histological cuts of the GI tracts of infected mice in order to determine whether VRE is 
predominantly located on the epithelial surface and embedded in the mucus, inside intestinal 
lining crevices, etc. This information could give us insight on what specific niches VRE occupies, 
thus facilitating the study and development of strategies against it. 
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As an alternative to immunofluorescence microscopy, GFP-like proteins are commonly 
used as transcriptional or translational fusion reporters. As a transcriptional fusion reporter, 
the promoterless gene which codes for the fluorescent protein is fused to the promoter of the 
gene of interest. Consequently, the transcriptional activity of the promoter can be measured 
through the analysis of fluorescence, since the fluorescent protein is synthesized whenever the 
target gene is being transcribed (Roberts and Pautsian, 2002). This allows for the 
monitorization of the transcriptional regulation of the target gene. However, it ignores any 
possible posttranscriptional effects. In contrast, in translational fusions, the fluorescent protein 
is made whenever the target gene is being transcribed and translated. In this method, the 
fluorescent gene is inserted between the C-terminal and N-terminal of the protein of interest, 
in-frame and preferably at a site that does not disrupt the proteins function or topology. The 
resultant protein is basically the target protein bearing a fluorescent tag. As GFP-like proteins, 
FbFP should also be suitable for this purpose and its great potential lies in its application for 
the analysis of gene expression in anaerobic environments, like the human GI tract (Lobo et al., 
2011). The use of these reporter proteins presents itself as an elegant alternative to 
immunofluorescence, for it not only allows in vivo real-time gene-expression monitorization, 
but can also be used for the determination of the localization, movement and interaction of 
gene products.  
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2. OBJECTIVES 
 
The main objective of this work is the generation of a Vancomycin-Resistant 
Enterococcus faecium clinical isolate (C68) expressing a (FMN)-based fluorescent protein 
(FbFP) which could serve as a practical tool for the study of key aspects of VRE’s colonization 
and persistence in the gut. These aspects remain practically unknown today but require special 
attention now that E. faecium has escalated to become a major public health concern.  
 
In order to accomplish the main objective, a series of partial objectives were proposed: 
 
1. The design and synthesis of a FbFP gene containing the necessary features for its adequate 
expression in E. faecium (Enterococcus codon-usage biased gene sequence, enterococcus 
constitutive promoter, and stop codon), as well as for its appropriate insertion into the pBT2 
plasmid (BamHI and SalI restriction sites). 
 
2. The generation of the pBT2-FbFP plasmid through the cloning of the fluorescent protein 
gene (FbFP) into pBT2 (in E. coli DH5a) and the subsequent verification of the integrity of the 
plasmid construction. 
 
3. The optimization of the transformation protocol for E. faecium through the adjustment of 
the transformation protocol used for E. faecalis. 
 
4. The successful transformation of E. faecium with the validated pBT2-FbFP plasmid 
construction. 
 
5. The use of fluorescence microscopy techniques to analyze the putative fluorescent 
properties of the transformed E. faecium cultured at different conditions. 
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3. MATERIALS AND METHODS 
 
3.1 Bacterial strains 
 
3.1.1 Escherichia coli DH5α 
 
E. coli DH5α strain (F– Φ80lacZΔM15 Δ (lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, 
mK+) phoA supE44 λ– thi-1 gyrA96 relA1) was used for the molecular cloning procedures of the 
EcFbFP gene. This strain is particularly useful for recombinant DNA methods and provides the 
means for high-efficiency transformations.  
 
3.1.2 Enterococcus faecium C68 
 
Enterococcus faecium C68 is a clinical isolate that represented the most prevalent VRE 
clone in 11 Cleveland hospitals in 1996 (Lam et al., 2012). At present, within the Enterococcus 
genus, E. faecium has emerged as the most therapeutically challenging organism.  C68 readily 
colonizes the mouse gastrointestinal tract under antimicrobial selective pressure (Rice et al., 
2009). Its genome has been completely sequenced (Lam et al., 2012). In this work, this strain 
was transformed with the pBT2 plasmid containing the EcFbFP insert, with the purpose of 
conferring it fluorescent properties. 
 
3.2 Plasmids 
 
3.2.1 pBT2  
 
pBT2 is a temperature-sensitive, 6.97 Kb  shuttle vector (Fig. 1) constructed from 
fragments of the pBR322 and pTV1Ts plasmids (Brükner, 1997). Some important features of 
the resulting plasmid include: origins of replication for E. coli and for Gram positive bacteria 
derived from the pBR322 and thermosensitive (does not replicate at 42 ºC) pTV1Ts plasmids 
respectively, ampicillin resistance  to E. coli and chloramphenicol resistance to Staphylococcus, 
E. coli and Enterococcus, in addition to a multiple cloning site derived from the pUC18 plasmid. 
It is important to highlight that chloramphenicol resistance is not used as the selective marker 
of choice for E. coli throughout the experiments due to the relatively low expression levels of 
the chloramphenicol acetyltransferase gene in this bacteria; ampicillin resistance is used for 
this purpose instead. 
 
 
 
 
 
 
 
 
Figure 1. Restriction map of the shuttle plasmid 
pBT2. Thin lines represent DNA derived from 
pBR322, and thick lines DNA derived from pTV1Ts. 
The location and orientation of resistance genes, 
origins of replication and the T1 transcriptional 
terminator are marked by arrows. Some restriction 
sites are shown. Restriction sites indicated in the 
multiple cloning site are unique. In addition, EcoRV, 
NheI, and PvuII may be used for cloning in pBT2 
(Brückner, 1997). 
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This plasmid was used to clone the FbFP gene into the BamHI, SalI sites, thereby 
generating the pBT2-FbFP plasmid. The plasmid was chosen to be temperature-sensitive as a 
requirement for steps that are to be carried out after the works described in this Final Degree 
Project. Basically, once the desired functional plasmid construction conferring E. faecium 
fluorescent properties is generated, there is intention to integrate the FbFP gene into the 
genome through recombination, and for this purpose, in order to select bacteria which have 
undergone recombination, temperature will be raised to provoke the plasmid loss. The 
bacteria which are able to grow in the selective media will prove to be recombinant. 
3.2.2 pUC57 
 
This plasmid was purchased from GenScript USA Inc. with the Enterococcus codon 
optimized cyan-green FbFP protein insert (441 bp). The gene was cloned into the EcoRV 
located in the multiple cloning site (MCS), as seen on (Fig. 2).It is important to highlight that 
the replication origin is only compatible with E.coli and that the gene is inserted promoterless.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Plasmid construct map of the pUC57 vector and multiple cloning site detail. The location and 
orientation of resistance genes and origin of replication are marked by arrows. The multiple cloning site 
(MCS) has been enlarged to show the exact location and the orientation of the FbFP gene (411 bp). 
 
3.2.3 pGLOW-KXN-Bs2 
 
The pGLOW-KXN-Bs2 is a 6957 bp bacterial expression vector that was purchased from 
Evoglow (Fig. 3). It is designed for the expression of an E. coli codon optimized FbFP. It contains 
a series of features like: both a constitutive promoter (aphII) for continuous expression and an 
IPTG-inducible T7 promoter (for a stronger induction of fluorescence), chloramphenicol and 
kanamycin antibiotic resistance genes, a gene for plasmid replication (rep) in a broad range of 
gram-negative bacteria, and a gene for plasmid mobilization (mob). This plasmid was aimed for 
its use as a positive control for fluorescence. This plasmid cannot be used directly in E. 
faecium, for the gene promoter and replication origins are not compatible. 
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Figure 3.  Restriction map of the pGLOW-KXN-Bs2 plasmid. The location and orientation of resistance 
genes (cmR), origin of replication (rep), EcFbFP (blue), constitutive promoter (aphII), inducible promoter 
(T7) and the mobilization gene (mob) are marked by arrows. A series of restriction enzymes are also 
displayed, in addition to their bp positions. 
 
3.5 Primers 
 
The oligonucleotide primers used in this work have been designed with vector NTI 
software. Primers EcFbFP-F-B, EcFbFP-R-S-2, T1-1R and Pbr322-1R were purchased from Isogen 
Life Sciences and FbFP-F3, FbFP-R4, EcFbFP-F5 and EcFbFP-R6 were purchased from Integrated 
DNA Technologies. 
 
Table 1. List of oligonucleotide primers used for PCR Amplification in this work. 
 
Primer Sequence Description Reference 
EcFbFP-
F-B 
 
GTCGGATCCGCTTGCATCAAAATAA
ACTACATGGGTATAATAGCAATGAA
ATGCATTTCAAAAATATTTTGAGGA
GAATTTAGTATGGCTTCATTCCAATC
ATTCGG 
“Insert-specific” forward primer used for 
PCR amplification of the FbFP from 
pCU57, and for the introduction of a 
promoter and a BamHI restriction site for 
cloning. 
This work 
EcFbFP-
R-S-2 
 
ACTGTCGACTTATTCTAATAATTTTT
CGTATTCTTTTTGTTTTGTG 
“Insert-specific” reverse primer used for 
PCR amplification of the FbFP insert from 
pCU57, and for the introduction of a stop 
codon and the SalI restriction site for 
cloning. 
This work 
T1-1R CGTTCACCGACAAACAACAG 
Forward primer flanking the multicloning 
site of pBT2. 
This work 
Pbr322-
1R 
ATTGCATCAACGCATATAGC 
Reverse primer flanking the multicloning 
site of pBT2. 
This work 
FbFP-F3 AGATCACGTTCGTGTTGGTG 
Forward primer designed to amplify an 
internal region of the FbFP insert of pBT2-
FbFP. Originally designed for Q-PCR. 
This work 
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FbFP-R4 TCAACTTCAGCTGGATCTGTGT 
Reverse primer designed to amplify an 
internal region of the FbFP insert of pBT2-
FbFP. Originally designed for Q-PCR. 
This work 
EcFbFP-
F5 
CACCGCGCTGCAAAATAAAG 
Forward primer designed to amplify an 
internal region of the EcFbFP insert of 
pGLOW-KXN-Bs2. Originally designed for 
Q-PCR. 
This work 
EcFbFP-
R6 
CCTTCTGCTTGGTGATGTCG 
Reverse primer designed to amplify an 
internal region of the EcFbFP insert of 
pGLOW-KXN-Bs2. Originally designed for 
Q-PCR. 
This work 
 
3.6 Culture and growth conditions 
 
Both the solid and liquid media detailed below (sections 3.6.1 and 3.62) were sterilized 
using an autoclave: 20 minutes at 1 atmosphere of pressure and 120 ºC. Temperature-
sensitive compounds, such as antibiotics, were added after autoclave sterilization, and only 
once the media was at a temperature below 50 ºC. Solid media was stored at 4 ºC; while liquid 
media was stored at room temperature (liquid media was not stored at 4 ºC, as antibiotics 
were added right before its use). Liquid cultures were grown in sterile flasks or falcon tubes on 
an agitated incubator tray to ensure an adequate aeration. However, it is important to 
highlight that when anaerobic conditions were required, cultures were grown in the anaerobic 
chamber. Solid cultures were grown in petri dishes stored in an inverted position, inside the 
incubator. 
 
3.6.1 Escherichia coli 
 
E. coli was grown at 37 ºC with agitation (220 rpm) in LB (Luria-Bertani) medium, 
composed of (1%(m/v) tryptone, 0.5% (m/v) yeast extract y 1% (m/v) NaCl). When required, 
ampicillin (reason discussed in section 3.2.1) was used for selection at a concentration of 100 
µg/mL. In order to prepare solid LB media, liquid LB was supplemented with agar (15 g/L). 
 
 
3.6.2 Enterococcus faecium 
 
E. faecium was grown at 37 ºC, or at 30 ºC (when carrying the temperature-sensitive 
pBT2 plasmid) with an agitation of 220 rpm in BHI medium, composed of: brain heart infusion 
from 250g ( 5 g/L), calf brains infusion from 200 g (12.5 g/L), disodium hydrogen phosphate 
(2.5 g/L), D(+)-glucose ( 2 g/L), peptone (10 g/L), sodium chloride (5 g/L) at pH 7.4±0.2 (25 
°C).  When needed, Chloramphenicol was used at a concentration of 12.5 µg/mL for selection 
purposes. When BHI agar medium was required, BHI broth was supplemented with agar (15 
g/L). 
 
The media for electroporation was prepared as described by (Li et al., 1995; Arias and 
Murray, 2012): 
 
-BYGT (BHI, yeast extract, glucose, Tris)  
Composition: 19 g/L BHI, 5 g/L yeast extract, 2 g/L dextrose, 12.1 g/L Tris; (pH=8). 
-BYGT Glycine (6%) 
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Composition: 19 g/L BHI, 5 g/L yeast extract, 2 g/L dextrose, 60 g/L glycine, 12,1 g/L Tris; 
(pH=8).  
-BYGT-Sucrose 
Composition: 19 g/L BHI , 5 g/L yeast extract, 2 g/L dextrose, 85.5 g/L sucrose, 12.1 g/L Tris; 
(pH=8). 
- Sucrose-MgCl2 
Composition: 213 g/L sucrose, 0,2 g/L Magnesium Chloride hexahydrate; (pH=4). 
 
3.7 DNA manipulations 
 
3.7.1 Plasmid extractions 
 
Plasmid DNA extractions were carried out using the “QIAprep Spin Miniprep Kit 
(Qiagen)”, following the “QIAprep Spin Miniprep Kit Using a Microcentrifuge” protocol on page 
22 of the QIAprep Miniprep Handbook. This procedure is based on the alkaline lysis of 
bacterial cells, followed by adsorption of DNA onto a silica-gel membrane in the presence of 
high salt concentrations, finally leading to the washing and elution of the plasmid DNA.  
 
It is important to highlight that plasmid extractions of E. faecium  required an 
additional step: resuspension of the overnight 5 mL culture cell pellet  in  250 µL  of the 
Enterococci lysis solution (9 g/L glucose, 3.46 g/L EDTA, 3.03 g/L TRIS and 5 mg/mL of lysozyme 
(pH= 8)) and incubation for  1 hour on ice. The following steps are to be carried out as starting 
on the second step of the “QIAprep Spin Miniprep Kit Using a Microcentrifuge” protocol.  
 
3.7.2 Conditions for PCR amplification 
 
PCR amplification reactions were routinely done in sterile microcentrifuge tubes, and 
all pre-PCR steps were carried out inside laminar flow cabinets. A PCR negative control (no 
DNA template) was always used to allow detection of contamination of the PCR reagents and 
positive controls were used when possible. 
 
Table 2. PCR reagents and concentrations. 
 
Reagent/Component Volume for one reaction (µL) 
H2O milli Q 19.375 
DNA Polymerase Buffer (10X) 2.5 
dNTPs (10mM) 0.625 
Taq Polymerase Enzyme (1U/ μL) 0.5 
Forward primer (10 mM) 0.5 
Reverse primer  (10 mM) 0.5 
DNA template  (∓ 10-20 ng) 1 
FINAL VOLUME 25* 
Note* Some PCR reactions were carried out for a final reaction volume of 50μL, thus all reagent volumes 
were doubled. 
 
All PCR amplification reactions were carried out in a thermal cycler (Techne TC-4000). 
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Table 3. PCR program. 
 
Step Temperature (ºC) Time (min) Number of cycles 
Initial denaturation 94 5 1 
Denaturation 94 0.5   
35 Annealing * 0.5  
Elongation 68 0.5  
Final elongation * 5 1 
Hold 4    
* Annealing temperatures depend on the different sets of primers used for each PCR reaction. See Table 
4 for the temperatures used for each pair of primers.  
 
 Table 4. Annealing temperatures used for each primer pair. 
 
Primer pairs Brief Description Temperature (ºC) 
EcFbFP-F-B and EcFbFP-R-S-2 Insert-specific 58 
T1-1R and Pbr322-1R vector –based/insert-flanking 56 
FbFP-F3 and FbFP-R4 E. faecium qPCR 56 
EcFbFP-F5 and EcFbFP-R6 E. coli qPCR 56 
  
3.7. 3 Colony PCR 
 
  Colony PCR was a quick and economical technique used to rapidly screen 
transformation products for positive clones after a ligation reaction, before double checking 
with double restriction enzyme digestions. Putative transformant colonies were resuspended 
in 15 µL of PBS in a 96-well plate. 3 µL of each colony solution were plated on selective media 
plates in order to have access to each colony in case the PCR indicated a positive 
transformation. 1 µL of the solution was used for PCR. Initial denaturation at 94 ºC lyses the 
cells, hence allowing PCR amplification of the gene, if present. It is important to highlight that 
the insert-flanking, vector-based primers were used (reasons discussed in section 4.5). 
 
3.7.4 Gel electrophoresis 
 
Agarose gel electrophoresis were performed with 1.4% agarose gels and using TBE 
(Tris/Borate/EDTA) 1X buffer solution (89 mM Tris (pH 7.6), 89 mM boric acid, 2 mM EDTA). 
The molecular weight marker used was “GeneRuler ™ , ready-to-use, 100-10000 bp DNA 
ladder Mix; 0.1µg/µL” (Thermo Scientific) and DNA samples were mixed with Loading MIX (50 
µL loading buffer 3X, 0.2 µL Gel Red) before loading them on the gel  wells (Sample-Loading 
MIX ratio = 1/4). All gels were run during a period of 25 min and a 20 volt electric field was 
applied. Gel results were visualized under U.V. light, taking the proper precautions, and 
photographs of the results were taken using a polaroid photo documentation camera.  
 
3.7.5 DNA quantification 
 
DNA quantification was required for many experiments in this work, such as 
quantification of plasmid extractions, quantifications of samples before digestions and 
ligations, to find out if large quantities of sample were lost during purifications, etc. For all DNA 
quantifications, the picogreen method was used. Picogreen is a very sensitive fluorescent 
nucleic acid stain used for the quantitation of double-stranded DNA. Quant-iT™ PicoGreen® 
dsDNA Assay Kit From Molecular Probes (Invitrogen) was used for this purpose. The reaction 
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itself consisted on mixing 1 µL of the sample with 24 µL of TE buffer and 25 µL of PicoGreen® 
dye (1:200; dye/TE ratio) in microcentrifuge tubes. The reaction was then incubated in the 
dark for 5 minutes to permit the dye to bind to double stranded DNA. The fluorescence of the 
samples was then measured with “QuantiFluor® dsDNA System (Promega)” at 
excitation/emission of 435/535 nm. 
 
 3.7.6 Restriction enzyme digestion of DNA 
 
All restriction enzymes and restriction buffers were purchased from New England 
BioLabs and were kept in ice at all times. Digestion reactions took place in 1.5 mL eppendorf 
tubes placed in a tube incubator for a period of 2 hours, at a temperature of 37 ºC. 
 
Table 5. Reagents and volumes used for the restriction enzyme digestions of DNA. 
 
Reagent Volume (µL) 
H20 milli Q 0** 
Buffer * 3 
Enzyme 1 0.5 
Enzyme 2 0.5 
DNA (0.1-0.5 µg) 26** 
Final Volume 30 
Note*: Buffer 3.1 was used for digestions with SalI and BamHI. In both cases, the selected buffer 
conferred 100% activity to both enzymes. 
Note**: The volume of water and DNA will vary in relation to the concentration of the DNA sample to be 
digested. 
 
3.7.7 DNA ligations 
 
The DNA concentrations of the insert and vector (quantified as indicated above), as 
well as their size ratio, were used to calculate the volume of each required for an optimal 
ligation reaction, using a 1:4 (vector/insert ratio). Calculations were made aiming for the use 
100 ng of pBT2 vector for the ligation reaction. The following formula was used: 
 
 
 
                         ng of vector X bp size of insert                                                    insert 
------------------------------------------------  X  molar ratio of     ---------------- 
           bp size of vector                                                          vector 
  
 
 
Once the nanograms of vector and insert required for the reaction were calculated, 
and having quantified the DNA concentrations previously, the volumes required for the 
ligation reaction were calculated by multiplying the ng of (insert or vector required) by their 
respective concentrations. 
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Table 6. Reagents and volumes used for the DNA ligation reaction. 
 
 Ligation reaction Ligation Control (without insert) 
Reagents Volume (µL) Volume (µL) 
H20 milli Q * * 
pBT2 plasmid (100 ng) * * 
EcFbFP gene insert * 0 
Buffer (10x) 2.5 2.5 
Ligase enzyme 1 1 
Final Volume 25 25 
Note *: These volumes depend on the calculations explained above.  
 
Ligation took place overnight in a thermocycler running a program which consisted in 
maintaining a steady temperature of 16 ºC. 
 
3.7.8 DNA purifications 
 
All DNA purifications which did not required extraction of DNA from a gel slice, such as 
the purification of DNA after digestion, were done using “Excela Pure 96-well plates” (EDGE 
BIO). Using this method, contaminants are filtered to waste under vacuum pressure and the 
purified DNA products are retained on the well membrane. Purified products are recovered 
after a quick elution and ready for immediate use. In these cases, deionized water was added 
until the volume was 100µL, and then they were left to rest 10 minutes inside a well.  After 
this, vacuum was applied to the plate until the wells were dry (10 min).Subsequently, 100µL of 
deionized water were used to resuspend the DNA sample. Again, the plate was left to rest 10 
minutes, followed by the same vacuum operation. Finally, DNA had been purified, and after 
resuspending it in 30-50 µL of water it was stored for future use.  
 
When Purifications required extraction of the DNA contained in a gel slice, (for 
example when the FbFP gene was amplified for its subsequent ligation with the pBT2 vector), 
the “High Pure PCR Product Purification Kit” was used in order to purify the amplicon from the 
agarose gel. Purification was therefore carried out once the desired DNA band was cut from 
the gel using an ethanol-cleaned scalpel on a UV light box, taking all the necessary precautions.  
     
3.7.9 RNA purifications 
 
RNA was extracted and purified with the “UltraClean® Microbial RNA Isolation Kit” 
(MO-BIO). This Kit is designed to obtain RNA from pure cultures of microorganisms. Through a 
bead beating technology, cells are lysed. Then, RNA is captured on a silica spin filter, washed 
and eluted in an RNase-free elution buffer. Finally, it is ready for reverse transcription and 
qPCR.  When working with RNA, all the special necessary precautions were taken. 
 
3.7.10 Sample storage 
 
All DNA samples, reagents and enzymes were stored in freezers at -20 ºC. RNA was 
stored at -80 ºC and bacterial strains were stored as frozen stocks, at -80 ºC, containing 15% 
glycerol. 
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3.8 Transformation 
 
3.8.1 E. coli 
 
E. coli DH5α cells were transformed using the heat-shock transformation method. This 
technique is performed once cells are chemically made competent (permeable to foreign 
DNA), by keeping the cells and plasmids on ice for a period of time, and briefly heating the 
mixture. The rapid change of temperatures causes the disruption of the membrane, hence 
allowing the entrance of the exogenous plasmids into the bacterial cells (Panja et al., 2008).  
 
3.8.1.1 Competent cell preparation 
 
For the preparation of competent cells, a colony of DH5α cells was inoculated in a 50 
mL falcon tube containing approximately 5 mL of LB broth for overnight culture (negative 
control for LB contamination was incubated parallelly).  24 hours later, 0.5 mL of overnight 
culture was inoculated in 12.25 mL of fresh LB broth. Cells were grown at 37 ºC, shaking at 220 
rpm until the OD600 (absorbance measured in a spectrophotometer, at a wavelength of 
600nm) was between 0.4-0.5 (generally, it took around 2 hours). It is important to mention 
that, from now on, all steps were carried on ice. Cells were centrifuged at 3750 rpm for 10 min 
at 4 ºC, and the pellet was resuspended in 6.25 mL ice-cold 0.1 M Calcium chloride. After a 30 
min incubation on ice, cells were centrifuged again (3750 rpm, 10 min at 4 ºC) and the pellet 
was resuspended gently in 200 µL of 0.1 M Calcium Chloride. 
 
3.8.1.2 Heat-shock transformation 
 
100 µL of the competent DH5α cell solution were mixed with 5µL of plasmid (2-10 
ng/µL) and incubated in ice for 30 min. The other 100 µL were used as a negative control (no 
plasmidic DNA was added). The heat shock was carried out by incubating the tubes at 42 ºC for 
90 seconds. After this, very quickly, 1 mL of fresh LB broth was added to both tubes, and then 
they were left shaking at 220 rpm for 40 min (37 ºC). Finally, transformed cells (and the 
negative control: transformation carried out without plasmid) were plated for overnight 
culture in LB plates with ampicillin (100 µg/mL) or kanamycin (50 µg/mL), used for selection 
purposes. The plated volume was 100 µL and glass beads were used for a more uniform 
spreading of the bacteria throughout the plate. Generally, the rest of tube’s volume was 
centrifuged; the pellet was resuspended in 100 µL of fresh media, and finally plated in order to 
increase the probability of obtaining transformant colonies, just in case the transformation 
was not very efficient. 
 
    3.8.2 E. faecium 
 
E. faecium cells were transformed using the electroporation transformation method. 
This technique also requires the bacterial cells to be made competent beforehand. The basic 
principle of this method is the brief exposure of the plasmid-cell mixture to a large electric 
pulse, which temporarily disturbs the cell membrane so that plasmid DNA molecules can pass 
into the cell. The transformation of E. faecium was achieved by following the protocol 
described previously by (Li et al. 1995, Arias and Murray, 2012), with a slight modification. 
 
3.8.2.1 Competent cell preparation 
 
For the preparation of the competent cells, E. faecium had to be grown in BYGT 
medium supplemented with a glycine concentration which led to optimal growth inhibition, for 
it has been found to help weaken the cell wall, hence enabling higher efficiency 
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transformations. E. faecium was grown overnight in BYGT supplemented with 4.8 % glycine. 
The overnight culture was diluted 10 fold in fresh BYGT with the same concentration of glycine 
(30 mL total) and incubated at 37 ºC for 1 hour. Afterwards, cells were chilled on ice, harvested 
by centrifugation (3750 rpm, 15 min at 4 ºC), and washed twice with chilled electroporation 
solution (sucrose-MgCl2), using ⅓ of the original volume (10 mL)). Finally, washed cells were 
resuspended in 500 µL of the sucrose-MgCl2 solution and then incubated on ice for 45 min.  
 
3.8.2.2 Electroporation transformation 
 
50 µL of the competent cells were mixed with 2 µg of purified plasmid DNA. The rest of 
the volume, up to 100 µL was filled up with more sucrose-MgCl2. Immediately after mixing, the 
solution was introduced in a clean chilled 0.2-cm cuvette and electroporated immediately with 
a Bio-Rad “Gene Pulser” apparatus at a capacitance of 25 mF, resistance of 200 V, and peak 
voltage of 2.5 kV (field strength of 8,750 to 10,000 V/cm). Cells were then incubated in 1 mL of 
BYGT-Sucrose solution for 2 hours, at 30 ºC (instead of 37 ºC due to the presence of the 
temperature sensitive plasmid inside the cells). Finally, tubes were centrifuged; the pellet was 
resuspended in 100 µL of BYGT-Sucrose solution, and plated with the aid of glass beads on BHI 
(containing chloramphenicol µg/mL) for overnight culture (30 ºC). Note that the 
electroporation process was also carried out without plasmidic DNA in order to have a negative 
control of the transformation process. 
 
3.9 Sequencing and sequence analysis 
 
Sequencing to verify the integrity of the FbFP gene insert cloned into the pBT2 plasmid 
was a necessary step. The Sanger Sequencing method was chosen for this purpose since it is 
the primarily used technology for small-scale sequencing operations and it allows especially 
long sequence reads (larger than 500 bp), an important characteristic taking into account the 
length of the FbFP insert (489 bp).The sequencing reaction was carried out with the BigDye 
Terminator V3.1 kit (Applied Biosystems) and resolved with a capillary sequencer from 
Sequencing Department of the University of Valencia. 
 
The BigDye Terminator V3.1 Cycle Sequencing Kit provides the required reagent 
components for the sequencing reaction in a ready reaction, pre-mixed format.  Reagents and 
volumes used to carry out the sequencing reaction can be seen on Table 7. 
 
Table 7. Reagents and volumes used for Sanger sequencing reactions. 
 
Reagents Volume ( µL) 
Deionized water 3 
BigDye® Terminator 5X Sequencing Buffer 1.6 
Primer (0.5mM)* 1 
BigDye® Terminator 0.4 
DNA sample 2 
Final reaction volume 8 
Note*: Each reaction was performed either with the forward or reverse primer, separately. 
 
A thermal cycler (Techne TC-4000) was used in order to carry out the sequencing 
reaction. The program used can be seen on the following table (Table 8). 
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Table 8. Sanger sequencing thermal cycler program. 
 
STEP Temperature (ºC) Time Cycles 
Denaturation 95 30 sec 99 
Annealing 56 5 sec 99 
Final elongation 60 4 min 99 
Hold 8   
 
  Chromatograms were analyzed with “4peaks” (program that enables visualization and 
editing of sequence trace files). Poor-quality sequenced regions were eliminated with this 
program and sequence integrity was confirmed by performing a BLAST on NCBI with the 
original FbFP gene sequence. 
 
 
3.10 Fluorescence microscopy 
 
  For the microscopy slides, bacterial colonies grown under the different conditions 
required (30ºC and 37 ºC, both under the presence and absence of molecular oxygen) were 
resuspended in 10 µL phosphate buffer saline (PBS) [4.3 mM dibasic sodium phosphate, 1.47 
mM monobasic potassium phosphate, 137 mM sodium chloride, 2.7 mM potassium chloride, 
pH 7.4]. A drop of this suspension was added to each slide, spread by dragging another slide 
along the first, and subsequently allowed to air-dry. The coverslips were mounted with 25 µL 
of glycerol (87%) once the slides were dry. 
 
All slides were analyzed with a Leica DM RXA2 Microscope and photographs were 
taken at 1000x magnification. CFP (Cyan Fluorescent Protein) filter was employed for 
fluorescent microscopy analysis: laser illumination aimed for maximal light absorption 
spectrum of FbFP (449 nm) and fluorescent emission was detected at 450 nm. Pictures of the 
same field views were also taken using “Nomarski” or Differential Interference Contrast (DIC) 
microscopy. In fluorescent microscopy images the background illumination was corrected by 
setting a common detection threshold with “ImageJ”, a public domain, Java-based program for 
scientific image processing. 
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4. RESULTS AND DISCUSSION 
 
4.1 Overview of the strategy used for the generation of a VRE faecium C68 expressing FbFP 
 
In order to fulfill the main objective of this work, a general workflow was designed (Fig. 
4). The first step consisted in synthesizing the fluorescent gene (FbFP), followed by a gene-
amplification step, which preceded the subsequent cloning steps into the pBT2 plasmid. The 
next step consisted in the transformation of E. coli DH5α with the resultant plasmid in order to 
obtain a large number of copies, as well as for confirming the presence and integrity of the 
plasmid construction. Finally, transformation of E. faecium C68 with the validated construction 
was carried out, with the objective of performing a fluorescence analysis, as well as for 
attempting an in vivo FbFP gene-expression assay. 
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Figure 4. General workflow of the main experimental process followed in this work. (A) Gene 
synthesis (pUC57 plasmid). (B) Design of the insert-specific primers (C) PCR amplification of FbFP and 
addition of the required features for correct expression in E .faecium and for its appropriate 
integration in the pBT2 plasmid.(D) Double digestion (BamHI/SalI) of the PCR products. (E) pBT2 
plasmid extraction. (F) pBT2 double-digestion (BamHI/SalI)(G)Ligation of the digested FbFP and pBT2. 
(H) Transformation of the pBT2-FbFP plasmid construction in DH5a. (I) Verification of the integrity of 
the plasmid construction through colony PCR, double digestion (BamHI/SalI), and insert sequencing. 
(J) Transformation of the validated pBT2-FbFP in E. faecium. (K) Fluorescent analysis of the E. faecium 
transformants. 
 
4.2 FbFP Gene synthesis 
 
4.2.1 pUC57 plasmid  
 
 The 411 bp gene sequence was obtained from the EcFbFP sequence that had been 
previously designed by (Drepper et al., 2007). However, the DNA sequence used in the article 
was adjusted to the E. coli codon usage bias: phenomenon where specific codons are used 
more often than other synonymous codons during gene translation (Behura and Severson, 
2013). It is thought that optimal codons help to achieve faster translation rates and higher 
accuracy, so the adjustment to Enterococci codon usage bias was carried out. This was 
achieved by using the codon-adaptation tool provided by (http://www.jcat.de/). Alignment of 
these two differently codon-biased sequences shows that their sequence differs significantly 
(Fig. Annex 1). However, although they are different nucleotide sequences, they code for the 
exact same amino acid sequence (Fig. Annex 2). 
 
 The modified sequence was sent to Genscript USA Inc. which synthesized the gene 
and cloned it into the 2710 bp pUC57 vector (Fig. 3). Upon arrival, pUC57 plasmid was 
transformed into E. coli DH5α cells. Transformed cells were of great interest at this point in 
time to generate large copy numbers for the extraction of as much insert-bearing plasmids as 
possible in order to carry out the following steps, and to simply act as containers of the 
plasmid for stock purposes. It is important to highlight that pUC57 plasmid only contains an 
origin of replication compatible with E. coli, hence the gene had to be cloned into a plasmid 
which could replicate in both E. coli and Enterococcus: pBT2. 
 
Now, the synthesis of a functional FbFP gene was not yet complete, two more factors 
had to be taken into account: the addition of a stop codon (nucleotide triplet at the end of the 
sequence to signal the termination of translation) and the addition of an appropriate promoter 
(DNA sequence that defines where transcription of a gene by the RNA polymerase starts) at 
the beginning of the sequence. Both features were designed to be introduced to the original 
sequence upon PCR amplification of the gene, by designing adequate primers bearing the 
promoter and stop codon. 
 
4.2.2 Oligonucleotide primer design and PCR amplification of the FbFP 
 
  As mentioned in the previous section, the promoter of the gene and the stop codon 
were designed to be introduced upon amplification of the FbFP gene. To make this possible, 
the primers for PCR amplification were designed to include these sequences, in addition to the 
appropriate restriction enzyme recognition sites which would allow its cloning into the pBT2 
plasmid (Fig. 9). The stop codon (TAA) was designed to be located adjacent to the sequence of 
the reverse primer which is complementary to the final base pairs of the gene sequence. The 
promoter was designed to be located adjacent to the sequence of the forward primer which is 
complementary to the first base pairs of the gene sequence. The promoter sequence is a 
constitutive promoter of the bacA gene of E. faecalis which had been used previously to 
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overexpress Enterococcal proteins (Toledo-Arana et al., 2001). It is of great importance to also 
mention that BamHI and SalI restriction restriction sites were included in the forward and 
reverse primers respectively. These sites were adjacent to the beginning of the promoter 
(BamHI) and behind the stop codon (SalI), and were designed to clone the FbFP gene into the 
pBT2 plasmid. Note that the 411 bp FbFP gene, upon amplification with these primers 
becomes 507 pb and when digested with BamHI and SalI: 501bp. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. “Insert-specific” oligonucleotide primers designed for PCR amplification of the FbFP insert, 
which parallely introduce a stop codon, a constitutive promoter and two restriction sites (BamHI and 
SalI) upon PCR amplification. (A) Color-coded sequences of the forward and reverse primers. The 
promoter sequence, originally from E. faecalis bacA gene, is represented in red. Restriction sites are 
shown in blue (gtcgac for SalI and ggatcc for BamHI). Stop codon is labeled in purple (note that it is the 
reverse complementary of TAA). The sequences labeled in green represent the regions of the primers 
which bind to the extremes of the FbFP gene. It is important to mention that the bases labeled in black 
(right before the restriction sites) represent extra bases New England Biolabs recommends for optimal 
restriction enzyme cleavage. (B) Schematic representation of how the insert-specific primers bind to 
the pUC57 plasmid PCR amplification. 
 
    A PCR amplification of the FbFP gene was carried out with the primers described 
above, and using the pUC57 plasmid extracted from one transformed DH5α colony as the DNA 
template. Two 50µL PCR reactions were carried out. A small amount was used to check for 
amplification through gel electrophoresis (Fig. 6A). A band of the expected size (507 bp) was 
observed, while no band of this size was observed in the negative control.  The rest of the 
reaction volume was run in an agarose gel (Fig. 6B), with the purpose of cutting the band and 
purifying the amplicon. Finally, the purified amplicon was quantified and its concentration was 
found to be 4.68 ng/µL. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Gel electrophoresis of the PCR amplification (using the insert-specific primers) of the FbFP 
inserted in pUC57. (A) Gel run with 4 µL of PCR product to check for amplification. Lanes 1 and 2 
correspond to two PCR amplifications of two plasmid extractions from one DH5α colony. The 3
rd
 lane 
EcFbFP-F-B (Forward primer) 
GTCGGATCCGCTTGCATCAAAATAAACT
ACATGGGTATAATAGCAATGAAATGCA
TTTCAAAAATATTTTGAGGAGAATTTAG
TATGGCTTCATTCCAATCATTCGG 
 
EcFbFP-R-S-2 (Reverse primer) 
ACTGTCGACTTATTCTAATAATTTTTCGT
ATTCTTTTTGTTTTGTG 
 
A B 
A B 
Results and Discussion 
22 
 
corresponds to a PCR negative control (water). The band observed on this lane is probably due to the 
formation of primer dimers. (B) Gel electrophoresis with the remaining PCR volume, aimed for band 
extraction. The dotted boxes represent the cutting of the bands for subsequent purification. Lanes 1 
and 2 correspond to one plasmid extraction and 3 and 4 the other. 
 
4.3 FbFP gene cloning 
 
4.3.1 Digestion and ligation of the pBT2 plasmid and the FbFP amplicon 
 
The amplified and purified FbFP insert, as well as the pBT2 plasmid, had to be double 
digested with the proper restriction enzymes (SalI and BamHI) (Fig. 4D, F) before they could be 
ligated to yield the resultant pBT2-FbFP plasmid construction (Fig. 4G). 
 
Since the pBT2 plasmid (recipient vector) had not yet been extracted, this was carried 
out from transformed DH5α cells, and quantification revealed it was at a concentration of 7.01 
ng/µL. Taking into account that the FbFP amplicon was at a concentration of 4.68 ng/µL and 
pBT2 at a concentration of 7.01 ng/µL, digestion conditions were set to match those described 
in materials and methods. After digestion, pBT2 and FbFP were purified to get rid of the 
restriction enzymes and the remainder cut off fragments. Subsequent quantification revealed 
that the digested and purified pBT2 and FbFP were at a concentration of 10.78 ng/µL and 
3.143 ng/µL respectively. 
 
The DNA concentrations of the insert and vector, as well as their size ratio, were used 
to calculate the volume of each required for an optimal ligation reaction, using a 1:4 
(vector/insert ratio).  
 
 
Calculations: 
 
DNA quantification results:  
- pBT2: 10.78ng/µL 
-FbFP: 3.143 ng/µL 
 
Using the formula described in materials and methods, the ng of plasmid and insert 
required for the ligation reaction were calculated the following way: 
 
 
 
                                  100  ng X ∓500 bp                                                 4 
                       -------------------------------------   X  molar ratio of    -------- = 34.1 ng FbFP 
∓7000 bp                                                       1          
 
 
 
Once the nanograms of vector and insert required for the reaction were calculated 
using the formula, and having quantified the DNA concentrations (of the purified digestions) 
previously, the volume required for the ligation reaction was calculated as follows: 
 
-Vector: (100 ng ) / (10.78 ng/µL) = 9.27 µL 
-Insert: (34.1ng) /( 3.143 ng/µL) = 10.84 µL 
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Table 9. Reagents and volume used for the DNA ligation reaction. 
 
 Ligation reaction Ligation Control (without insert) 
Reagents Volume (µL) Volume (µL) 
H20 milli Q 1.39 12.23 
pBT2 plasmid (100 ng) 9.27 9.27 
FbFP gene insert 10.84 0 
Buffer (10x) 2.5 2.5 
Ligase enzyme 1 1 
Final Volume 25 25 
 
4.3.2 Transformation of DH5α with the ligation product   
 
The ligation product was transformed into DH5α cells to verify the presence and 
integrity of the desired plasmid construction and for its propagation (Fig. 4H). This was done as 
a previous step to the transformation of E. faecium C68. At first glance, it may seem as if 
validating the plasmid construction in DH5α, rather than directly doing it on the bacterial strain 
of interest (E. faecium C68) is a waste of time.  However, the reason why E. faecium C68 was 
not chosen is due to the fact that E. coli DH5α is an ideal strain for routine cloning procedures, 
specially designed to enable highly efficient transformations, a very convenient trait when 
trying to transform a ligation product, since these are commonly very inefficient. By using 
DH5α, several tedious and inefficient limiting steps can be bypassed.  
 
4.3.3 Verification of the correct insertion of FbFP in pBT2 
 
4.3.3.1 Colony PCR screening 
 
After transformation of DH5α cells, the colony-PCR technique was utilized as a 
preliminary screening method for determining which transformed colonies indeed had 
incorporated the desired plasmid construction. In order to perform the colony PCR, a different 
pair of primers was used to amplify the FbFP gene. These primers were designed to bind to the 
flanking regions of the site where FbFP was supposedly cloned into (Fig. 7). These vector-based 
primers were used as a precaution method to avoid the obtention of false positive colony-PCR 
bands that could occur if the insert-specific primers (primers used for the FbFP amplification 
step) were to be used. This false positive phenomenon could happen, for example, if non-
inserted FbFP molecules were carried along with the ligation volume used for the 
transformation, and were plated onto the culture media along with the transformant cells. As 
the number of FbFP molecules that could be present on the plate is very large, and only one 
molecule could give rise to a false positive, chances are that when picking a colony, non-
inserted FbFP molecules could be accidentally picked up into the PCR mixture at the same 
time, potentially leading to the observation of false positives. Therefore, the best way of 
making sure FbFP had been inserted correctly into pBT2 was to use insert-flanking, vector-
based primers. 
 
 
 
 
 
 
 
 
 
Figure 7. Schematic representation of the manner in which 
the “vector-based”, “insert-flanking” primers bind to the 
pBT2-FbFP plasmid for PCR amplification. 
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To carry out the colony-PCR, 9 colonies that had grown overnight in the selective 
media were picked and amplified using the vector-based, insert-flanking primers. An agarose 
gel was run with the colony-PCR products (Fig. 8). The expected fragment size is about 1000 
bp, since the insert is roughly 500 bp and the sum of the amplifiable parts of the plasmid is also 
about 500 bp). 
 
 
 
 
 
 
 
 
 
 
Figure 8. Colony PCR results. Lanes 1-9 show the colony PCR products for the 9 colonies that were 
picked. Lane 10 shows the PCR product of the pBT2 plasmid. Since it has no FbFP insert, the amplified 
region is the sum of the amplifiable flanking regions (roughly 500 bp); it acts as the positive control. Lane 
11 shows the PCR product of the pUC57 plasmid in which primers cannot bind, hence acting as a 
negative control. A negative control for the PCR reaction is shown on lane 12 (water). The band triplets 
observed on the upper part of lanes 10 and 11 shows the 3 different plasmid migration types. 
 
According to the molecular marker, the bands which correspond to this size are those 
pertaining to colonies 3, 5 and 8. Additionally, by analyzing the gel, one can easily see that 
colonies 2, 6 and 7 were transformed with a plasmid which did not contain the insert, for the 
amplified fragment corresponds to the sum of the vector’s amplifiable flanking regions (about 
500 bp), a band size also displayed by the negative control (pBT2 without insert, tenth lane). 
This could most probably be the result of a poor digestion: either, neither BamHI nor SalI 
digested pBT2, or alternatively, only one of them was able to digest the plasmid, which 
subsequently re-ligated (the double-digestion scenario followed by the plasmid's re-ligation is 
not contemplated, for BamHI and SalI produce distinct cohesive ends). Finally, colonies 1 and 9 
show bands which correspond to excessively large sized fragments, most likely ligation 
artifacts. It is important to note that the bands observed at the lower part of the gel in all lanes 
are PCR by-products: primer dimers.  
 
  4.3.3.2 Restriction enzyme double-digestion 
 
Once colony-PCR had pinpointed colonies 3, 5 and 8 as the major candidates for 
containing the desired plasmid construction, plasmid was extracted from each of these 
colonies with the intention of doing a restriction enzyme double-digestion with BamHI and 
SalI. Restriction enzyme digestions give more accurate results and serve as a double-check to 
faithfully determine if the colonies indeed carry the recombinant pBT2-FbFP plasmid. Figure 9 
very neatly displays how all three colonies (3, 5 and 8) undoubtedly possess the FbFP insert, 
since a band corresponding to its size (about 500 pb) is observed in all gel lanes except the 
negative control (pBT2 plasmid without insert). Additionally, an intense band corresponding to 
the plasmid’s expected size can be seen in the upper part of all gel lanes (negative control 
included). 
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4.3.3.3 pBT2-FbFP insert sequencing 
 
An important step during the cloning of a gene into a plasmid is the verification of the 
inserted sequence through its DNA sequencing, a recommended step before advancing to any 
further operations. Since the FbFP sequence had undergone many steps of amplification and a 
great deal of handling, the possibility that it may have had acquired mutations or suffered any 
kind of modification throughout the process was not discarded. For this reason, pBT2-FbFP 
plasmid was extracted from colony 3 (see previous section) for sequencing analysis.  
 
Sequencing was achieved by means of the Sanger Sequencing method (see materials 
and methods). Sanger sequencing was carried out with the reverse insert-specific primer: 
EcFbFP-R-S-2 (Fig. 10A), and with the forward vector-based primer: T1-1R (Fig. 10B) 
Surprisingly, Sanger sequencing performed with the reverse and forward primers both  
revealed a point mutation in the FbFP gene, where an Adenine nucleotide was exchanged for a 
Guanine (Fig. 10A, B).  Alignment of the mutated sequence of FbFP and the original FbFP 
sequence is shown reveals a mismatch (Fig. Annex 3).These types of substitution mutations 
are known as transition mutations, and, in contrast to transversion mutations, are much more 
frequent and involve interchanges of similarly-shaped bases: interchanges of two-ringed 
purines (A / G) or of two-ringed pyrimidines (C /T). Fortunately, this was also a silent mutation, 
for it did not result in a change in the amino acid sequence of FbFP; the affected codon was 
changed to a synonymous one. Alignment of the mutated and original FbFP translated 
sequences demonstrates amino acid sequence identity (Fig. Annex 4). 
 
 
          Forward (T1-1R) 
TTTTATTTGATGCCTCAAGCTAGAGAGTCATTACCCCAGGCGTTTAAGGGCACCAATAACTGCCTTAAAAAAATTACGCCCCGCCCTGCCACTCAT
CGCAGTGCAGCGGAATTCGAGCTCGGTACCCGGGGATCCGCTTGCATCAAAATAAACTACATGGGTATAATAGCAATGAAATGCATTTCAAAAA
TATTTTGAGGAGAATTTAGTATGGCTTCATTCCAATCATTCGGTATCCCAGGTCAATTAGAAGTTATCAAAAAAGCTTTAGATCACGTTCGTGTTG
GTGTTGTTATCACAGATCCAGCTTTAGAAGATAACCCG*ATCGTTTACGTTAACCAAGGTTTCGTTCAAATGACAGGTTACGAAACAGAAGAAA
TCTTAGGTAAAAACGCTCGTTTCTTACAAGGTAAACACACAGATCCAGCTGAAGTTGATAACATCCGTACAGCTTTACAAAACAAAGAACCAGTT
ACAGTTCAAATCCAAAACTACAAAAAAGATGGTACAATGTTCTGGAACGAATTAAACATCGATCCAATGGAAATCGAAGATAAAACATACTTCGT
TGGTATCCAAAACGATATCACAAAACAAAAAGAATACGAAAAATTATTAGAATAAGTCGACCTGCAGGCATGCAAGCTTTAATGCGGTAGTTTAT
CACAGTTAAATTGCTAACGCAGTCAGGCACCGTGT 
 
         Reverse (EcFbFP-R-S-2) (reverse complementary) 
AAAATAAACTACATGGGTATAATAGCAATGAAATGCATTTCAAAAATATTTTGAGGAGAATTTAGTATGGCTTCATTCCAATCATTCGGTATCCCA
GGTCAATTAGAAGTTATCAAAAAAGCTTTAGATCACGTTCGTGTTGGTGTTGTTATCACAGATCCAGCTTTAGAAGATAACCCG*ATCGTTTACG
TTAACCAAGGTTTCGTTCAAATGACAGGTTACGAAACAGAAGAAATCTTAGGTAAAAACGCTCGTTTCTTACAAGGTAAACACACAGATCCAGCT
GAAGTTGATAACATCCGTACAGCTTTACAAAACAAAGAACCAGTTACAGTTCAAATCCAAAACTACAAAAAAGATGGTACAATGTTCTGGAACGA
ATTAAACATCGATCCAATGGAAATCGAAGATAAAACATACTTCGTGGATCCAAAA 
Figure 10. Sanger sequencing reads for colony 3: Forward and reverse. (A) Sequence output obtained 
by sequencing the insert using the forward “vector-based” primer. (B) Reverse complementary 
sequence of the sequence output obtained by sequencing the insert using the reverse “insert-specific” 
primer. (A,B) Color code: Orange = pBT2 plasmid; Purple = stop codon; Green = Insert; Red = bacA 
promoter. The AG mutation has been highlighted in yellow and marked with an asterisk.  
Figure 9. Gel electrophoresis displaying the 
digestion products of the pBT2-FbFP 
construct. Lanes 1, 2 and 3 correspond to 
digestions of the plasmids extracted from 
colonies 3, 5 and 8 (Fig. 8). Lane 4 is a negative 
control: pBT2 plasmid (without FbFP). The 
FbFP insert (about 500 bp) is observed in all 
three colonies. 
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4.3.4 Transformation of E. faecium  
 
4.3.4.1 Optimization of the Enterococci transformation protocol 
 
Transformations in E. faecalis have been well described  in the past by (Li et al. 1995, 
Arias and Murray, 2012) in which growth media is supplemented  with  glycine (6%), for it has 
been observed that, although having an inhibitory effect on bacterial growth, it enables greater 
transformation efficiencies, probably through the debilitation of the cell wall. Even though 
previous studies with E. faecalis had shown a 70 to 90 % reduction in optical density at OD600 
(the so called “optimal growth inhibition”) when supplementing with 6 % glycine, E. faecium 
did not tolerate such high amounts. Consequently, experiments to test different glycine 
concentrations were carried out with the purpose of determining a suitable glycine 
concentration that would enable efficient E. faecium transformations. 
 
First, an experiment testing a series of glycine concentrations was designed. In this 
experiment, E. faecium was grown overnight in an array of BYGT cultures, supplemented with 
different glycine percentages (0, 0.375, 0.75, 1.5, 3 and 6) (Table 10).  Growth inhibition was 
assessed by comparing the absorbance of each overnight culture with the absorbance of a 
culture containing no glycine. It is important to mention that since the darkness of the media 
increased with glycine addition, absorbance blanks containing the same glycine percentage as 
the samples were performed before each sample measure. This precaution was aimed to avoid 
the bias the increase in darkness would have produced to the readings.  
 
Table 10.  Results of the 1
st
 experiment designed to test the inhibitory effects of an array of glycine %. 
 
Glycine % Absorbance (OD600) Growth inhibition (%) 
0 1.741 0 
0.375 1.732 0.5 
0.75 1.556 10.6 
1.5 1.389 20.2 
3 1.257 27.8 
6 0.001 99.94 
 
A sudden drop in the growth was observed between cultures containing 6% and 3% 
glycine (Table 11)  Inhibition was  still too far away from the optimum growth inhibition 
described by (Arias and Murray, 2012), so a second experiment was carried out, though this 
time,  testing intermediate glycine percentages:  3, 3.6, 4.2, 4.8, 5.4, and 6%. 
 
Table 11.  Results of the 2
nd
 experiment designed to test the inhibitory effects of an array of glycine %. 
 
Glycine % Absorbance (OD600) Growth inhibition 
0 1.577 0 
3 1.504 2.3 
3.6 1.557 1.3 
4.2 1.508 4.4 
4.8 0.575 63.5 
5.4 0.021 98.7 
6 0.008 99.5 
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Again, a sudden growth drop was observed, this time between the cultures 
supplemented with 4.8 and 5.4 % glycine.  As the growth inhibition optimum described 
previously was close to the inhibition achieved with 4.8% glycine, transformation of E. faecium 
with this concentration was attempted.  
 
4.3.4.2 Transformation of E. faecium C68 with pBT2-FbFP 
 
Transformation of E. faecium was performed as described in materials and methods 
(Fig. 4J). Two putative transformants (colonies grown on the selective media plates) were 
grown for plasmid extraction. A gel was run with extracted plasmid from two colonies (Fig. 11). 
As it can be observed, the DNA appears degraded, as a light smear. This is not suitable for a 
restriction enzyme digestion analysis, for it would not yield results. It could be possible that 
genomic DNA was sheared, and thus could not be isolated well from the plasmidic DNA. 
Parallelly, nucleases from Enterococci could have partially degraded the plasmid, and so an 
indirect method to find out if E. faecium is really a transformant would be to re-transform 
DH5a with the poorly-extracted pBT2-FbFP plasmid. This would be an interesting technique 
since DH5a is an endonuclease free strain: mutation “endA” in the Endonuclease I eliminates 
the non-specific endonuclease activity, allowing for more efficient plasmid extractions. 
Obtention of DH5α transformants would enable the verification of the integrity of the plasmid 
since the strain has proven to yield highly enriched plasmid extractions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.4.3 Indirect confirmation of the transformation of E. faecium with pBT2-
FbFP 
 
As discussed in the previous section, transformation of E. coli DH5a with the 
presumptive pBT2-FbFP plasmid (extracted from hypothetical E. faecium transformants) was 
carried out in order to indirectly determine whether E. faecium had successfully undergone 
transformation or not. Transformation procedure was executed as described in materials and 
methods.  
 
After transformation, PCR amplification of the FbFP insert was performed with the 
vector-based, insert-flanking primers, using extracted plasmid as the PCR template. Gel 
electrophoresis for the PCR products (Fig. 12A) revealed bands which correspond to the 
expected amplicon size (roughly 1000 bp); thereby indirectly demonstrating that E. faecium 
had indeed been successfully transformed with the pBT2-FbFP vector.  
 
An additional experiment was carried out in order to double check the results exposed 
by the previous gel. The experiment consisted in a double digestion with BamHI and SalI 
(restriction enzymes used for cloning FbFP into pBT2) of the extracted plasmid. The results 
Figure 11. Agarose gel run with the plasmid extractions of two 
putative E. faecium transformants. Lanes 1 and 2 correspond to 
extractions from two different colonies. Lane 1 shows a very 
unsuccessful extraction, a very light smear is observed. Lane 2 is 
similar, but much more intense. It is possible that in this lane, the 
different conformation migrations of the plasmid can be 
observed (Arrows). 
bp 
 3000  
1000    
   500  
M 1 2 
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from this experiment confirmed the previous findings, for the gel that was run with the 
digestion products (Fig. 12B) displayed bands which correspond to the FbFP expected insert 
size (around 500 bp) and no band on the negative control. Note that the upper band seen for 
all lanes corresponds to the plasmid. As a result, it can be said that DH5a cells were 
transformed with the pBT2-FbFP plasmid which was extracted from the E. faecium, and 
therefore, although obtained indirectly, there is sufficient evidence as to confirm the 
successful transformation of the latter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. (A) Gel results for the PCR amplification of the FbFP insert performed with the vector-
based, insert-flanking primers, using extracted plasmid (from DH5a) as the PCR template. Lanes 1 and 
2 corresponf to two extractions (2 colonies) of pBT2-FbFP. Lane 3 represents a positive control for the 
amplification (pBT2 without FbFP insert) and lane 4 probably shows the formation of primer dimers on 
the negative control for the PCR reaction(water). (B) Agarose gel showcasing the results of double-
digestion reaction (BamHI and SalI) of the extracted pBT2-FbFP. Lanes 1 and two represent the two 
extractions (FbFP insert is present) and lane 3 a digestion of the pBT2 plasmid without insert (negative 
control). Upper bands reflect the presence of the plasmids.  
 
4.5 Analysis of fluorescence 
 
Once the transformation of E. faecium with pBT2-FbFP was confirmed, visualization of 
the bacteria through a fluorescent microscope was of great importance, as this technique had 
the potential to confirm whether or not the main objective of this work had been achieved 
(Fig. 4K). In order to carry out this task, an experiment was carefully designed to mimic the in-
vivo niche conditions of this bacterium and meet all other experimentally relevant demands.   
 
In the first place, since the use of the intended fluorescent E. faecium C68 is principally 
aimed for its use in anaerobic environments (such as the GI tracts of animals), the experiment 
was designed in such a way as to, not only study the fluorescent properties of FbFP under 
aerobic conditions, but very importantly, also under anaerobic conditions. This experimental 
design parallelly allowed the confirmation of previous studies which claimed that FbFP, in 
contrast to GFP-like proteins, is equally fluorescent in the presence and absence of molecular 
oxygen (Drepper et al. 2007). 
  
Secondly, it is important to mention that up until this point in time, all culturing steps 
which involved the transformed E. faecium had been carried out at 30 ºC as a precautionary 
measure, since pBT2 is a temperature-sensitive plasmid and temperatures close to 42 ºC 
would prompt its loss. However, since the temperatures of the GI tracts of the animal hosts of 
this bacterium are usually around 37 ºC, avoiding to carry out the experiments at this 
temperature, whilst continuing to perform them at 30 ºC, would constitute a failure in the 
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experimental design. Therefore, both aerobic and anaerobic cultures were cultured at both 30 
ºC and 37 ºC, as it enabled to determine if FbFP is expressed similarly and can be folded 
equally well at both temperatures. Moreover, this design also provides the means to 
experimentally determine whether the plasmid is lost at 37 ºC or not. 
 
     As part of a proper fluorescence experimental design, a positive control which is 
fluorescent under the same conditions as those to which the samples are subjected is always 
required. To serve this purpose, E. coli DH5a was transformed with a plasmid containing the 
EcFbFP gene which would confer it with florescent properties: pGLOW-KXN-Bs2 plasmid (look 
at materials and methods for more information).  
 
The presence of the plasmid containing the gene was confirmed by performing a PCR 
amplification of an internal region of the EcFbFP gene, using extracted plasmid as the PCR 
template (Fig. 13) It is important to draw attention to the fact that the positive control was 
cultured under all the different conditions E. faecium was subjected to (37 ºC and 30ºC, both 
under anaerobic and aerobic conditions). Negative controls for both E. coli and E. faecium 
transformants were also designed. These consisted in both of the bacterial species without 
undergoing transformation. However, these were only tested under one condition (37 ºC; 
aerobic), since they did not contain a plasmid with the FbFP gene and were merely used to 
check that the strains did not have already fluorescent properties, as well as for comparison 
with fluorescence intensities obtained by the transformants. 
 
 As an additional control which would indicate the presence of bacteria (even if they 
did not display fluorescence), microscopic photographs of all conditions were taken using DIC 
(Differential Interference Contrast; Nomarski) microscopy, in addition to the pictures (of the 
same field of view) taken through fluorescent microscopy. Fluorescence and DIC microscopy 
analysis was carried out as described in materials and methods. 
 
 
 
 
 
 
 
 
 
 
 
 
     Since no significantly relevant differences were observed when comparing the 
fluorescent results of the different sets of conditions (temperature and oxygen presence), only 
the results which correspond to the anaerobe experiment carried out at 37 ºC (closest in-vitro 
conditions to the in-vivo gut environment) are displayed below (Fig. 14). However, the rest of 
the images exhibiting the remaining conditions tested can be observed on Fig. Annex 5. The 
fact that all conditions display the same general result indicates that conclusions obtained 
from just analyzing the condition shown in the figure below can be extrapolated to the rest of 
conditions, since neither the temperature range used or the presence/absence of oxygen 
appear to have a differential effect on the expression and function of the fluorescent protein.  
 
It is important to mention that as the signals of interest appeared very dim, long 
camera exposures were applied to enhance image background contrast. However, this was 
problematic, as it gave rise to the detection of certain autofluorescence which interfered with 
Figure 13. Confirmation of the Transformation of DH5a cells 
with the commercial plasmid. Lane 1 corresponds to the PCR 
product of the amplification of an internal region of the EcFbFP 
insert using extracted plasmid as template. An  amplicon 
corresponding to the expected size (about 200 bp) confirms the 
presence of the gene. Lane 2 represents the negative control for 
the PCR (water) 
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the detection of the bacterial fluorescence of interest. Although very dull, some degree of 
autofluorescence signals can be observed on the negative controls (Fig. 14 B, D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14.  Fluorescence CFP (Cyan Fluorescen Protein) filter microscopy and Differential Interference 
Contrast; Nomarski) microscopy photographs (1000x) taken with the Leica DM RXA2 Microscope. In 
each panel (A,B,C,D), pictures on the left were taken with the CFP filter and the pictures on the right 
with DIC.  (A) DH5a cultured at 37ºC under anaerobic conditions, transformed with the pGLOW-KXN-
Bs2 (positive control). Bacteria show fluorescence when compared to its negative control (B): DH5a 
cells without the plasmid. (C) E. faecium cultured at 37ºC under anaerobic conditions, transformed 
with the pBT2-FbFP plasmid. Although the intensity of signal is slightly higher that the negative control 
(D), suggesting that the FbFP protein is expressed, though at very low levels compared to the positive 
control (A), the results are not conclusive as to faithfully determine that FbFP is responsible for the 
signal observed. 
 
Without doubt, the DH5a positive control displays fluorescence in comparison to the 
negative control (Fig. 14A, B). However, fluorescence emissions originated by E. faecium are 
not so clear. It is hard to determine if the signals obtained are really the product of FbFP 
expression or simply very dim false positives resulting from autofluorescent signals. At first 
glance, signals appear to be more intense than those observed on the negative control, 
suggesting that the fluorescent protein may be expressed, though at very low levels (Fig. 14C, 
D). Nevertheless, it could also be argued that autofluorescence intensity could appear higher 
than on the negative control as a consequence of a higher aggregation of bacteria.  
 
It is clear that further studies are required to complement fluorescence microscopy in 
shedding light upon this ambiguous issue. For instance, Real-Time quantitative PCR analysis  of 
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the expression of FbFP in E. faecium would be an interesting approach to find out if the gene is 
expressed, and if so, how much. Additionally, if the gene was shown to be expressed, a 
western blot could be carried out to determine if the gene is translated, and if it is the case, at 
what levels is the protein found inside the cells. 
 
4.6 RNA extractions for q-PCR 
 
     As mentioned in the previous section, measurement of FbFP gene transcription 
would be an interesting approach to complement and possibly clarify the results obtained 
through fluorescence microscopy, as it would allow to determine that FbFP is expressed. This 
technique is known as Real Time/Quantitative-PCR (q-PCR), and it requires the previous 
extraction of the RNA from the cells, as well as its retro-transcription into double stranded 
cDNA. 
 
     It is important to highlight that a certain volume of cells (cultured under the different 
conditions used for the microscopy experiment explained in the previous section) was used to 
extract RNA, both from the transformed E. faecium and the positive DH5a control. RNA 
extractions were carried out as explained in materials and methods. A gel was run with the 
extraction products with the purpose of assessing the extraction results (Fig. 15). As it can be 
seen, the bacterial rRNA bands corresponding to 23S (~2,900 bases) and 16S (~1,500 bases) are 
visible. The blurred appearance of these bands, along with the presence of smears indicates 
that the RNA may be partly degraded, phenomenon which is especially pronounced for RNA 
extractions from DH5a cells.  
 
As surprising as it may seem at first glance, taking into account that the same 
procedure was carried out for both bacterial samples, the fact that DH5a RNA extractions 
present a poorer quality may be explained by a simple detail: the type of bacterial cell wall. 
Since DH5a is a Gram-negative bacteria (containing a thin peptidoglycan layer), in contrast to 
E. faecium, which is Gram-positive (thicker peptidoglycan layer), it is quite possible that during 
the mechanical lysis step of  the RNA extraction, the higher rigidity of the Enterococcus cell 
wall attributed this bacteria a higher resistance to disruption. In turn, DH5a may have lysed 
very early in this mechanical process, hence provoking a premature shearing of its RNA. Adding 
to this theory, the spherical coco shape of E. faecium, in comparison to the rod-like shape of 
DH5a may confer the first an even greater resistance to disruption. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Gel electrophoresis of the total RNA extracted from transformed DH5a and E. faecium cells. 
Lanes 1-4 show RNA extracted from Dh5a and lanes 5-8 show RNA extracted from E. faecium. Bands for 
the 16s rRNA and 23S rRNA are indicated.   
 
23S 
16S 
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To make sure the RNA extraction had successfully isolated RNA from any DNA trace of 
the FbFP gene (even though the extraction protocol contained a step designed to eliminate 
DNA traces through DNAse 1 digestion), PCR amplification of an internal region of this gene 
was performed, using the primers originally designed for the q-PCR. Surprisingly, as displayed 
by the gel electrophoresis carried out with the PCR products (Fig. 16), all sample lanes showed 
a band corresponding to the amplicon’s expected size (roughly 200 bp). This clearly indicated 
that there were still traces of the FbFP gene, since the Taq polymerase cannot use RNA as a 
template.  
 
 
 
 
 
 
 
 
 
 
 
Figure 16. PCR amplification of the total RNA extractions from transformed DH5a and E. faecium, 
using primers for the amplification of an internal region of EcFbFP and FbFP respectively. Lanes 1-4 
correspond to DH5a samples and lanes 8-11 correspond to E. faecium samples. Lanes 5 and 12 show the 
positive controls for PCR amplification, pGLOW-KXN-Bs2 and pBT2-FbFP plasmids respectively. Lanes 6 
and 13 show bands corresponding to the primer dimers formed in the negative controls (water). An 
amplicon corresponding to the expected amplicon size (about 200 bp) is observed for all samples and 
the positive controls, indicating the contamination of all RNA samples 
 
The quality and purity of RNA samples are critical parameters for reliably obtaining 
accurate and reproducible gene expression analyses. Performing a q-PCR without eliminating 
FbFP gene traces would result in false positives, since amplification would be observed for all 
samples, though it would be impossible to determine whether this was due to the presence of 
the desired retro-transcribed RNA or the original FbFP gene. For this reason, an additional 30 
minute DNAse 1 digestion step was carried out (see materials and methods). However, PCR 
continued to show amplification, though at a lesser degree (Fig. 17).  
 
An ultimate attempt was made to eliminate all traces of DNA. Since the last digestion 
had significantly lowered the amount of contaminating DNA it was thought that a greater 
digestion time would solve the problem. Two additional digestions were designed: one lasting 
45 minutes and the other 60 minutes. Gel results for the PCR amplification are shown on (Fig. 
17). It can be seen that the results for both digestions are very similar: practically no 
amplification is observed for DH5a samples and some amplification can be observed for E. 
faecium samples, specially the last two lanes.  
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Figure 17. Gel electrophoresis of the PCR products obtained from the amplification of the total RNA 
extracted from DH5a and E. faecium and after 45 (A) and 60 (B) minute digestions with DNase1. For 
both figures (A,B), lanes 1-4 represent DH5a samples and lanes 7-8 represent E. faecium samples. Lanes 
5 and 11 represent the negative controls for the PCR reaction (water), and lanes 6 and 12 show the 
amplicons obtained when amplifying pGLOW-KXN-Bs2 and pBT2-FbFP plasmids respectively (positive 
controls). FbFP gene contamination is still observed after 45 and 60 minute digestions, especially in E. 
faecium samples. 
Although there were still DNA remnants in some samples, and thus not suitable for 
pPCR, it was interesting to run a gel with the digested RNA (Fig. 18). This allowed to determine 
if the incubation temperatures used in the digestion had a negative effect on its quality, since 
it is widely known that RNA is very delicate, and the temperatures used for the digestion were 
considerably high (37 ºC for incubation and 65 ºC for DNAse1 inactivation). As expected, 
although the presence of DNA contamination was shown to be negatively correlated to the 
time of DNAse1 incubation, apparently so did the quality of RNA (Fig. 15 and 18).  
 
 
 
 
 
Figure 18. Agarose gel run with the DH5a and E. faecium RNA extractions after 45 and 60 minute 
digestions with DNase1. Lanes 1-8 correspond to RNA samples after a 45 minute digestion (lanes 1-4 
show DH5a samples, and 5-8 show E. faecium samples). Lanes 10-17 correspond to RNA samples after a 
60 minute digestion (lanes 10-13 show DH5a samples, and 14-17 show E. faecium samples. It can be 
seen that RNA sample quality decreases after the addition of DNAse1, compared to (Fig. 15). 
These results suggest that a different approach, other than augmenting the digestion 
time, is required. Perhaps, increasing the enzyme concentration and decreasing the RNA 
amount rather than the digestion time, or simply by purchasing a commercial kit designed for 
this purpose, such as the Agilent Total RNA Isolation Mini Kit, specially devised for efficient 
removal of transfected plasmid DNA from total cellular RNA. 
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4.7 Additional Experiments 
As a result of time frame restrictions, no additional experiments were able to be 
performed. However, it is of great importance for the understanding of this work as a whole to 
highlight the experiments which need to be carried out.  
Firstly, once a method for extracting and purifying RNA which yields suitable RNA for 
pPCR analysis is developed, FbFP gene-expression analyses should be performed. qPCR will 
complement the results obtained through fluorescence microscopy analysis in this work, 
indicating whether no expression is achieved with the plasmid construct or if the expression 
levels are very low. In either case, the substitution of the promoter bacA used would be a good 
idea, since this promoter is originally from E. faecalis, not E. faecium. Therefore, it would be of 
great interest to try a strong promoter pertaining to an E. faecium gene. However, this task 
would be difficult, as there is a great lack of information in relation to strong constitutive 
promoters in E. faecium. 
Once suitable intensity levels of fluorescence are achieved, the integration of the 
fluorescent gene into the genome should be carried out in order to avoid the loss of 
fluorescence, as plasmids can be lost through successive bacterial divisions. For this purpose, 
sites for recombination would need to be cloned flanking the inserted FbFP gene. These sites 
would be identical to regions in the genome to enhance recombination. Additionally, a gene 
terminator should be cloned after the FbFP gene insert to avoid the continuation of gene 
transcription when integrated. As explained in materials and methods, recombinant bacteria 
would be selected by growing them at 42 ºC, hence enhancing the loss of the temperature 
sensitive plasmid. Upon plasmid loss, bacteria that continue displaying fluorescent properties, 
but have become sensitive to chloramphenicol (due to plasmid loss) would therefore be 
products of recombination. 
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5. CONCLUSIONS 
- The design and synthesis of a (FMN)-based fluorescent protein gene containing the necessary 
features for its expression in E. faecium and for its appropriate insertion into the pBT2 plasmid 
has successfully been achieved. 
- Different analyses focused on the validation of the integrity of the pBT2-FbFP plasmid 
construction in transformed E. coli DH5a cells have evidenced the correct insertion of the FbFP 
gene into the pBT2 plasmid. 
- The application of the transformation protocol used by (Arias and Murray, 2012) for E. 
faecalis has shown to be inadequate for the transformation of E. faecium. Adjustment of the 
glycine concentration used for the preparation of competent cells, from 6% to 4.8% glycine, 
although not attaining the optimum growth inhibition (70-90% reduction), has proven to yield 
efficient transformations in this bacterium. 
- pBT2-FbFP plasmid extractions from transformed E. faecium cells did not allow for down-
stream validation analysis of the integrity of the transformed plasmid. However, 
transformation of E. coli DH5a cells with the poorly extracted plasmid from E. faecium has 
demonstrated to be an indirect, yet very practical operation for this purpose. 
 
- Fluorescence analysis of FbFP-expressing bacteria grown under different culturing conditions 
has revealed that, at least in E. coli DH5a, FbFP shows no signs of differential expression under 
aerobic and anaerobic conditions, thereby confirming the results obtained by other 
researchers in the field (Drepper et al, 2007). 
 
- Fluorescence analysis of putative FbFP-expressing E. faecium transformants was not enough 
for definitely concluding that this bacterium had acquired fluorescent properties. The fact that 
the images taken with the fluorescent microscope show mildly enhanced intensity differences 
with the negative control suggest this bacterium might express the FbFP, although at very low 
levels, hence indicating that the design novel strategies to achieve an adequate expression of 
FbFP in E. faecium are required.  
 
- Total RNA was successfully extracted from both E. coli and E. faecium with the purpose of 
conducting qPCR analyses which would complement and possibly clarify the results obtained 
through fluorescence microscopy. However, DNA containing the FbFP gene was also extracted 
with the RNA, contaminating all samples, and defeating the purpose of performing qPCR. 
 
- The experiments designed to eliminate the DNA contamination from the RNA extractions 
through the augmentation of digestion’s incubation times with DNase1 did not result in RNA 
outputs suitable for qPCR analysis. FbFP gene DNA traces remained in some samples and RNA 
quality declined considerably with incubation time. Alternative methods for the elimination of 
contaminating DNA need to be studied. 
 
- It is clear that additional work will be required in order to complement the results obtained in 
this Final Degree Project. qPCR and western blot analysis present themselves as the most 
suitable techniques with the potential of ultimately clarifying whether FbFP expression in E. 
faecium has legitimately been achieved, and to design novel strategies to achieve and 
adequate expression of FbFP in E. faecium. 
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7. ANNEX 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure Annex 1. Alignment of the original EcFbFP nucleotide sequence (E. coli codon-biased) and the 
modified FbFP sequence used in this work (Enterococcus codon-biased). Vertical lines (|) represent 
matched bases and dots (.) represent mismatches. Although they are different nucleotide sequences, 
they code for the exact same amino acid sequence (Fig. A2). 
 
 
 
 
 
 
 
 
Figure Annex 2.  Alignment of the translated EcFbFP and FbFP (aligned on Fig. A1). Vertical lines (|) 
represent matched bases and dots (.) represent mismatches. No dots are observed, meaning that the 
translated sequences are identical. In a sense, although the nucleotide sequences are different, they 
code for the same amino acid sequence 
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# Length: 489 
# Identity:     488/489 (99.8%) 
# Similarity:   488/489 (99.8%) 
# Gaps:           0/489 ( 0.0%) 
# Score: 2436.0 
#======================================= 
 
EMBOSS_001         1 GCTTGCATCAAAATAAACTACATGGGTATAATAGCAATGAAATGCATTTC     50 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001         1 GCTTGCATCAAAATAAACTACATGGGTATAATAGCAATGAAATGCATTTC     50 
 
EMBOSS_001        51 AAAAATATTTTGAGGAGAATTTAGTATGGCTTCATTCCAATCATTCGGTA    100 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001        51 AAAAATATTTTGAGGAGAATTTAGTATGGCTTCATTCCAATCATTCGGTA    100 
 
EMBOSS_001       101 TCCCAGGTCAATTAGAAGTTATCAAAAAAGCTTTAGATCACGTTCGTGTT    150 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       101 TCCCAGGTCAATTAGAAGTTATCAAAAAAGCTTTAGATCACGTTCGTGTT    150 
 
EMBOSS_001       151 GGTGTTGTTATCACAGATCCAGCTTTAGAAGATAACCCAATCGTTTACGT    200 
                     ||||||||||||||||||||||||||||||||||||||.||||||||||| 
EMBOSS_001       151 GGTGTTGTTATCACAGATCCAGCTTTAGAAGATAACCCGATCGTTTACGT    200 
 
EMBOSS_001       201 TAACCAAGGTTTCGTTCAAATGACAGGTTACGAAACAGAAGAAATCTTAG    250 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       201 TAACCAAGGTTTCGTTCAAATGACAGGTTACGAAACAGAAGAAATCTTAG    250 
 
EMBOSS_001       251 GTAAAAACGCTCGTTTCTTACAAGGTAAACACACAGATCCAGCTGAAGTT    300 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       251 GTAAAAACGCTCGTTTCTTACAAGGTAAACACACAGATCCAGCTGAAGTT    300 
 
EMBOSS_001       301 GATAACATCCGTACAGCTTTACAAAACAAAGAACCAGTTACAGTTCAAAT    350 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       301 GATAACATCCGTACAGCTTTACAAAACAAAGAACCAGTTACAGTTCAAAT    350 
 
EMBOSS_001       351 CCAAAACTACAAAAAAGATGGTACAATGTTCTGGAACGAATTAAACATCG    400 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       351 CCAAAACTACAAAAAAGATGGTACAATGTTCTGGAACGAATTAAACATCG    400 
 
EMBOSS_001       401 ATCCAATGGAAATCGAAGATAAAACATACTTCGTTGGTATCCAAAACGAT    450 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       401 ATCCAATGGAAATCGAAGATAAAACATACTTCGTTGGTATCCAAAACGAT    450 
 
EMBOSS_001       451 ATCACAAAACAAAAAGAATACGAAAAATTATTAGAATAA               489 
                     ||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       451 ATCACAAAACAAAAAGAATACGAAAAATTATTAGAATAA               489 
 
Figure Annex 3.  Alignment of the FbFP sequence obtained by Sanger sequencing the FbFP insert of 
pBT2-FbFP plasmids extracted from “colony 3” (see section 4.4.2.3) and the original FbFP sequence. 
Vertical lines (|) represent matched bases and dots (.) represent mismatches. A single mismatch is 
observed (highlighted in yellow), indicating that a mutation has occurred at some point during the 
handling process (transition from AG). The affected codon is highlighted in green. 
# Length: 138 
# Identity:     138/138 (100.0%) 
# Similarity:   138/138 (100.0%) 
# Gaps:           0/138 ( 0.0%) 
# Score: 713.0 
 
EMBOSS_001         1 MASFQSFGIPGQLEVIKKALDHVRVGVVITDPALEDNPIVYVNQGFVQMT     50 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001         1 MASFQSFGIPGQLEVIKKALDHVRVGVVITDPALEDNPIVYVNQGFVQMT     50 
 
EMBOSS_001        51 GYETEEILGKNARFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYKKDGT    100 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001        51 GYETEEILGKNARFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYKKDGT    100 
 
101 MFWNELNIDPMEIEDKTYFVGIQNDITKQKEYEKLLE*    138 
    |||||||||||||||||||||||||||||||||||||  
101 MFWNELNIDPMEIEDKTYFVGIQNDITKQKEYEKLLE*    138 
 
Figure Annex 4.  Alignment of the translated original and mutated sequences of FbFP. Vertical lines (|) 
represent matched bases and dots (.) represent mismatches. As it can be seen, there are no 
mismatches. The amino acid sequences are identical since the (AG) mutation produced a codon chage 
(CCACCG) which codes for the same amino acid (Proline). Therefore, it can be said that it is a silent 
mutation, having no effect on the final protein output. 
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Figure Annex 5. Fluorescence microscopy (CFP filter) and Differential Interference Contrast; Nomarski 
microscopy photographs (1000x) taken with the Leica DM RXA2 Microscope. See section 4.5 for a 
detailed explanation of the experiment. (A) DH5a cultured at 37ºC under aerobic conditions (B) E. 
faecium cultured at 37ºC under aerobic conditions (C)DH5a cultured at 30ºC under aerobic conditions 
(D) E. faecium cultured at 30ºC under aerobic conditions. (E) DH5a cultured at 30ºC under anaerobic 
conditions. (F) E. faecium cultured at 30ºC under anaerobic conditions. (G) Negative control: DH5a 
(without pGLOW-KXN-Bs2) (H) Negative control: E. faecium (without pBT2-FbFP). It can be seen how 
transformed DH5a cells indeed display fluorescent properties, in comparison to the negative control. 
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However, although the images suggest that transformed E. faecium cells are slightly more fluorescent 
than the negative control, the intensity is not conclusive. Changes in temperature or the 
presence/absence of molecular oxygen appear to have no effect on the fluorescence emission. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
